Abstract
SummaryGruel obtained from experimental thromboatherosclerotic plaques and from human coronary artery plaques was tested in in vitro studies for its possible thromboplastic potency. Gruel from experimental thromboatherosclerotic plaques was moderately thrombogenic, but that obtained from the human plaque appeared to be non-thrombogenic. The lipid extract of the experimental gruel failed to exhibit any thrombogenic propensity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
